Related Experiment Video
Updated: May 16, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
T-Cell Exhaustion in the Tumor Microenvironment: Subcellular Dysfunction, Pan-Cancer Characteristics, and Therapeutic
Mingxing Wang1,2, Wanhui Dong3, Jian Chen1
1Shanghai TCM-integrated Hospital, Shanghai University of TCM, Shanghai, China.
Subcellular organelle dysfunction drives T-cell exhaustion in cancer immunotherapy. Targeting these organelle checkpoints offers novel strategies to enhance anti-tumor T-cell responses.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Immune checkpoint blockade (ICB) therapy is crucial for cancer treatment.
- T-cell exhaustion (Tex) limits ICB efficacy in solid tumors.
- Subcellular organelle dysfunction in T cells within the tumor microenvironment (TME) is understudied.
Purpose of the Study:
- To review the role of subcellular organelle dysfunction in T-cell exhaustion.
- To explore how organelle interactions contribute to T-cell dysfunction.
- To summarize therapeutic strategies targeting organelle checkpoints.
Main Methods:
- Systematic review of literature on T-cell exhaustion and organelle function.
- Analysis of organelle interaction networks (mitochondria, ER, nucleus, lysosomes).
- Summary of T-cell subcellular dysfunction across different solid tumors.
Main Results:
- Suborganellar dysfunction is a key driver of T-cell exhaustion.
- Dysregulated organelle networks (mitochondria, ER, nucleus) create a self-sustaining cycle of T-cell dysfunction.
- Specific organelle defects are observed in various solid tumors, including lung and liver cancers.
Conclusions:
- Subcellular organelle dysfunction is a critical mechanism underlying T-cell exhaustion.
- Targeting organelle homeostasis and function presents promising therapeutic avenues.
- Subcellular engineering approaches can enhance T-cell-mediated anti-tumor immunity.
More Related Videos
06:16Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
08:42Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
Published on: June 27, 2025
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Tumor Immunotherapy
Treatment Resistant Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...